Navigation Links
PharmAthene Submits Proposal to BARDA in Response to Broad Agency Announcement for Advanced Research and Development for Valortim(R)
Date:6/2/2009

rmation presented herein, matters discussed may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are not historical facts, including statements preceded by, followed by, or that include the words "potential"; "believe"; "anticipate"; "intend"; "plan"; "expect"; "estimate"; "could"; "may"; "should"; or similar statements are forward-looking statements. PharmAthene disclaims, however, any intent or obligation to update these forward-looking statements. Risks and uncertainties include risk associated with the reliability of the results of the studies relating to human safety and possible adverse effects resulting from the administration of the Company's product candidates, unexpected funding delays and/or reductions or elimination of U.S. government funding for one or more of the Company's development programs, including without limitation our bid related to SparVax(TM) under the DHHS Request for Proposals for an Anthrax Recombinant Protective Antigen (rPA) Vaccine for the Strategic National Stockpile, the award of government contracts to our competitors, unforeseen safety issues, challenges related to the development, scale-up, and/or process validation of manufacturing processes for our product candidates, unexpected determinations that these product candidates prove not to be effective and/or capable of being marketed as products, as well as risks detailed from time to time in PharmAthene's Forms 10-K and 10-Q under the caption "Risk Factors" and in its other reports filed with the U.S. Securities and Exchange Commission (the "SEC"). In particular, there can be no assurance that the Company will be awarded a contract under the solicitation under BAA-BARDA-09-34. .Further, significant ad
'/>"/>
SOURCE PharmAthene, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA
2. PharmAthene to Host a Conference Call and Webcast on Wednesday, April 29th at 4:30 PM to Provide an Update on the SparVax(TM) rPA Anthrax Vaccine Program
3. PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R)
4. PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop
5. PharmAthenes Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimers Disease
6. PharmAthene to Webcast its Third Quarter Conference Call on November 13, 2007 at 4:30 P.M. Eastern Time
7. Human Genome Sciences Submits Biologics License Application to FDA for ABthrax(TM)
8. Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
9. D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to the FDA for Phase III Trial of DP-b99 in Acute Stroke Patients
10. AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product
11. U.S. Naval Medical Research Center Resubmits IND Application for Proposed RESUS Clinical Trial in Trauma Patients in the Out-of-Hospital Setting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... MENLO PARK, Calif. , May 29, ... (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical ... therapies in new orphan drug indications, presented additional ... Cancer Research (AACR) Advances in Brain Cancer Research ... product candidate VAL-083 (dianhydrogalactitol) to treat ...
(Date:5/29/2015)... 2015 Educating the community continues to ... the Advancement of Wound Care (AAWC), which was ... AAWC,s corporate partners, the Association provides medical professionals ... AAWC website at http://aawconline.org/education-for-the-generalist/ . The portal ... links to various CME/CEU educational programs. This education ...
(Date:5/28/2015)... , May 28, 2015 ... has announced the addition of Jain PharmaBiotech,s ... Companies"  to their offering.  ... (RNAi) or gene silencing involves the use ... the cell, this material is processed into ...
Breaking Medicine Technology:DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5The Association for the Advancement of Wound Care Educates the Public 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 3
... N.Y., July 17 Strong National,Museum of Play ... of the,American Journal of Play, the first interdisciplinary ... The inaugural issue enters the scholarly scene ... the most prominent national,researchers and writers in the ...
... to data from other, technologies -, ... Bradmer Pharmaceuticals Inc.,(TSX: BMR), a biopharmaceutical company dedicated ... released progression free,survival (PFS) data from two previously ... (GBM) patients. As an exploratory,endpoint of the single ...
Cached Medicine Technology:Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008 2Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 2Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 3Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 4Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 5
(Date:5/29/2015)... 2015 The Recovery Village at ... and co-occurring mental health treatment facility, will host ... the general public on June 1st, and will ... Village at Palmer Lake will offer affordable detox, ... traditional and evidence-based therapies, in a luxurious setting ...
(Date:5/29/2015)... Richey, FL (PRWEB) May 29, 2015 According ... nearly one in 10 full-time workers has a substance abuse ... 2012 from more than 111,500 adults with full-time jobs, revealed ... disorder in the previous year. (1) The National Council on ... $81 billion per year, and an estimated 70% of the ...
(Date:5/29/2015)... Jan Wooden Howse lost her husband and ... all else: God does no wrong. , It’s fitting, then, ... passing is titled “God Does No Wrong.” It focuses on ... personal tragedy. , “My story has a positive message ... into something productive, something healing,” Howse said. , “God Does ...
(Date:5/29/2015)... The Healthcare Delivery Institute at ... Advanced Training Program (ATP) in Healthcare Delivery Improvement. ... their health care organization ranging from clinicians to ... continuous quality improvement in the health care environment. ... James’ internationally recognized Advanced Training Program at Intermountain ...
(Date:5/29/2015)... Intermountain Healthcare of Salt ... Stratus Video Interpreting for on-demand medical ... and timely care for patients with limited ... video remote interpreting (VRI) services will supplement ... quickly access qualified medical interpretation in nearly ...
Breaking Medicine News(10 mins):Health News:Advanced Recovery Systems Announces the Opening of The Recovery Village at Palmer Lake 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 3Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 4Health News:Turning grief from a child’s passing into virtue 2Health News:HORNE LLP’s Healthcare Delivery Institute Graduates Class from the Advanced Training Program 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 3Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 4
... , CHICAGO, July 30 The ... scientific/medical society dedicated to advancing research and clinical pursuits that ... lifespan, unveils an innovative, technology-based fix to healthcare with the ... lifespan, or improve the healthspan, of all Americans by 29+ ...
... ... Expense Hardship During a Time of Family Crisis. , ... Las Vegas, NV (PRWEB) -- Once upon a time Denise found herself in the ... had been a terrible motorcycle accident involving his son. She was very close to her ...
... ... the firm is now offering ElderCare/PrimePlus services. ElderCare/PrimePlus is a service wherein the staff ... that elderly persons can remain living independently, with dignity, and assured of receiving the care ... ...
... ... information. , ... 2009 -- Businesses looking to lease commercial space can easily compare the cost and value ... Group of Tucson (CREGT). ,The Lease With Ease calculator offers easy access to lease ...
... typical dose of a medication considered pivotal in treating ... modern-day physiques, UT Southwestern Medical Center researchers said. ... August edition of Antimicrobial Agents and Chemotherapy , ... by obesity, said Dr. Tawanda Gumbo, associate professor of ...
... Osteotech Reports Second Quarter 2009 Financial Results , ... Launches and Unveilings in the Third Quarter , , ... , , Call on July 30, 2009 at 10:00 ... Osteotech, Inc. (Nasdaq: OSTE ), a leader in the emerging field ...
Cached Medicine News:Health News:Obama White House Can Save $3.7 Trillion and Extend Lifespan 29+ Years, Predicts Revolutionary A4M Healthcare Plan 2Health News:Prepaid Emergency Travel Announces a Unique Service That Provides Peace of Mind During Family Emergencies 2Health News:The Mills Group LLC Announces ElderCare/PrimePlus Service 2Health News:Commercial Real Estate Group of Tucson Unveils Online Tool that Quickly Informs Commercial Real Estate Tenants of Lease Options 2Health News:Higher drug doses needed to defeat tuberculosis, UT Southwestern researchers report 2Health News:Higher drug doses needed to defeat tuberculosis, UT Southwestern researchers report 3Health News:C O R R E C T I O N -- Osteotech, Inc. 2Health News:C O R R E C T I O N -- Osteotech, Inc. 3Health News:C O R R E C T I O N -- Osteotech, Inc. 4Health News:C O R R E C T I O N -- Osteotech, Inc. 5Health News:C O R R E C T I O N -- Osteotech, Inc. 6Health News:C O R R E C T I O N -- Osteotech, Inc. 7Health News:C O R R E C T I O N -- Osteotech, Inc. 8Health News:C O R R E C T I O N -- Osteotech, Inc. 9
Enhanced drug and formulary reference with integrated ID treatment guide and tools. Increase patient safety and satisfaction with our premium drug reference....
... STELLARA™ is HIPAA-compliant wireless technology that ... hospital departments and personnel a reality. ... four tages or levels ... patient care, shorter hospital stays and ...
The Duran Flexible Annuloplasty System encompasses both performance and practicality....
... Eppendorf Reference Series 2000 Pipette is a ... a compact and robust design, and superior ... used to operate the measuring stroke and ... Product features:Eppendorf "pipette/tip" system ensures utmost accuracy ...
Medicine Products: